Karg, Elisabeth (Blue Ribbon Partners 202011 Project Manager) |
n. a. |
Blue Ribbon Partners GmbH |
|
Klingan, Franz-Robert (Bain & Co 201610 Partner) |
Consultant (economic/technology) |
Bain & Company |
|
Miller, Tom (GreyBird Ventures 201908 Partner + 201908– Board Chairman at GNA Biosolutions) |
Partner (venture partner) |
GreyBird Ventures |
|
Geigle, Peter (CMBlu Energy 202310 CEO + Founder) |
Chief Executive Officer (CEO) |
CMBlu Energy (Group) |
Alzenau |
Pöpping, Bert (FOCOS GbR 201703– Co-Owner before Mérieux NutriSciences + GROFOR + Eurofins) |
Research & Development Manager |
FOCOS GbR (FOCOS Food Consulting) – Dr. Bert Pöpping + Dr. Carmen Diaz-Amigo |
Alzenau |
Hansen, Dirk (Phenomenex 201003 Marketing Manager Europe) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Aschaffenburg |
Föll, Armin (GC biotech 200809) |
n. a. |
GC biotech (Group) |
Augsburg |
Hagen, Alexander (Synlab 201603 Group Head of Marketing + Communications) |
Sales Manager / Marketing Manager |
Synlab (Group) |
Augsburg |
Lindauer, Andreas (Synlab 200702) |
n. a. |
Synlab (Group) |
Augsburg |
Romero, Petra (Plasmion 202301 Marketing Manager) |
Sales Manager / Marketing Manager |
Plasmion (Group) |
Augsburg |
Valor, Santiago (Synlab 201603 CMO) |
Chief Medical Officer (CMO) |
Synlab (Group) |
Augsburg |
Wimmer, Bartl (Synlab 201408 Managing Director) |
Managing Director |
Synlab (Group) |
Augsburg |
Wolf, Jan-Christoph (Plasmion GmbH 201806 Managing Director) |
Managing Director |
Plasmion (Group) |
Augsburg |
Wolf, Thomas (Plasmion 202301 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Plasmion (Group) |
Augsburg |
Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
Babraham, Cambridgeshire |
Deininger, Werner (Entelechon GmbH 200709 Managing Director) |
Managing Director |
Eurofins (Group) |
Bad Abbach |
Fischer, Markus (PolyQuant 201306 Managing Director + Entelechon GmbH 200709 Managing Director) |
Managing Director |
PolyQuant GmbH |
Bad Abbach |
Ulyanova, Elena (Entelechon 201208 Business Development + Marketing Manager at PolyQuant GmbH) |
Business Development Manager / Strategy Manager |
PolyQuant GmbH |
Bad Abbach |
Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Bad Homburg |
Bourdon, Christophe (Leo Pharma 202204– CEO before Orphazyme + Amgen + Alexion) |
Managing Director |
Leo Pharma (Group) |
Ballerup |
Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Versant Ventures |
Basel BS |
Emmerich, Wolf-Dieter (Netzsch Instruments) |
Consultant (economic/technology) |
Netzsch (Group) |
Bayern_o |
Günther, Kathrin (BioVariance 201710 Director Marketing + Sales Business Development) |
Business Development Manager / Strategy Manager |
BioVariance GmbH |
Bayern_o |
Iann, Max Markus (Iann 2012– Founder) |
Investment Manager |
Iann (Group) |
Bayern_o |
Mann, Wolfgang (Olympus before Advalytix AG before Alopex GmbH Managing Director) |
Managing Director |
BlueCatBio (BCB) (Group) |
Bayern_o |
Niemeier, Eckhard (Pieris 201708 VP Business Development) |
Business Development Manager / Strategy Manager |
Pieris (Group) |
Bayern_o |
Roth, Matthias (Seiratherm 201202 Managing Director) |
Managing Director |
Seiratherm GmbH |
Bayern_o |
Vogeser, Gudrun (PIKA Weihenstephan GmbH 201308 Managing Director + Co-founder) |
Managing Director |
PIKA Weihenstephan GmbH |
Bayern_o |
Wieloch, Peter (Ingenium Medical Diagnostics 202012 Managing Director + Co-Founder) |
Managing Director |
Ingenium Digital Diagnostics GmbH |
Bayern_o |
Xu, Caroline Man (ViGeneron 201911 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ViGeneron GmbH |
Bayern_o |
Rösch, Paul (Univ Bayreuth 201504 Professor at Research Center for Bio-Macromolecules) |
Professor |
University of Bayreuth |
Bayreuth |
Senker, Jürgen (Univ Bayreuth 201802– Prof of Inorganic Chemistry + Head of Northern Bavarian NMR Centre) |
Professor |
University of Bayreuth |
Bayreuth |
Platte, Ulrich (eTheRNA Immunotherapies 202110 CFO formerly sinYmed UG 201510– Managing Director) |
Chief Financial Officer (CFO) |
eTheRNA (Group) |
Belgium_oo |
Buth, Ines-Regina (akampion 200901 before Micromet Head Investor Relations before Lion Bioscience) |
Public Relations Manager / Investor Relations Manager |
Akampion |
Berlin |
Kääb, Georg (Biocom AG 202109– Managing Editor of |transkript before GoingPublic + BioM) |
Editor / Publisher |
Biocom (Group) |
Berlin |
Maschek, Uwe (MagForce 200705–200912 CEO resigned 12/09 before Cephalon GmbH 1997–2007 Managing Director) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Berlin |
Rüdiger, Manfred (Ariceum Therapeutics 202206 CEO before Catalym + Affectis + Kiadis Pharma + LSP Munich) |
Chief Executive Officer (CEO) |
Ariceum Therapeutics (Group) |
Berlin |
Buchberger, Bernd (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Bernried |
Fischer-Knuppertz, Wulf (CellTool 202001– CEO before Biocrates 201306–201909 + Fisher Scientific + Roche Diagnostics) |
Chief Executive Officer (CEO) |
CellTool GmbH |
Bernried |
Heinrich, Günther (Epidauros Founder) |
Company Founder |
Danaher (Group) |
Bernried |
Kaspar, Dagmar (Epidauros 200707– VP BusDev + Marketing before Nordic Bioscience) |
Business Development Manager / Strategy Manager |
Danaher (Group) |
Bernried |
Mutter, Wolfgang (Hyglos 200903– Manager Director before Profos CEO before Roche Diagnostics GmbH Penzberg) |
Managing Director |
Mérieux (Group) |
Bernried |
Müller, Günter (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Bernried |
Müller-Späth, Reinhard (P.A.L.M. 200412 CEO) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Bernried |
Reschauer, Stephan (Epidauros 200603 Patents + Licensing) |
n. a. |
Danaher (Group) |
Bernried |
Roschmann, Elke (Epidauros 200707– promoted to Head Strategic Development + Licensing) |
n. a. |
Danaher (Group) |
Bernried |
Schütze, Karin (CellTool GmbH 201912 Managing Director + Co-Founder) |
Managing Director |
CellTool GmbH |
Bernried |
Walter, Monika (Hyglos 2010 Manager Operations) |
Chief Operating Officer (COO) |
Mérieux (Group) |
Bernried |
Leppert, Angelika (Kupando 202209 CFO before Bavaria (govt) 202004 Start-up Coach, Strategy + Corporate Finance) |
Chief Financial Officer (CFO) |
Kupando GmbH |
Brandenburg_o |
Kaib, Roland (Infoteam Software 201402 Key Account Manager Medical Devices) |
Sales Manager / Marketing Manager |
Infoteam Software (Group) |
Bubenreuth |
Schmid, Ingrid (Infoteam Software 201404 Key Account Manager Life Science) |
Sales Manager / Marketing Manager |
Infoteam Software (Group) |
Bubenreuth |
Bäuerle, Patrick (MPM Capital 201710 Managing Director formerly Micromet) |
Managing Director |
MPM Capital (Group) |
Cambridge, MA |
Hummel, Berthold (Baker McKenzie 202106 before Dechert) |
Attorney / Lawyer |
Baker McKenzie LLP |
Chicago, IL |
Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Darmstadt |
Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
Chief Executive Officer (CEO) |
Affectis Pharmaceuticals AG |
Dortmund |
Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
Chief Medical Officer (CMO) |
Affectis Pharmaceuticals AG |
Dortmund |
Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen) |
Managing Director |
Abalos Therapeutics GmbH |
Düsseldorf |
Becker, Thomas |
n. a. |
Eurofins (Group) |
Ebersberg |
Grimminger, Carola (Eurofins 201410 Marketing Manager at Eurofins Genomics GmbH) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Ebersberg |
Huber, Jutta (Eurofins 201405 Managing Director Eurofins Genomics GmbH before MWG Biotech) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Koehler, Uwe (Eurofins 201603 Head Gene Synthesis + Molecular Biology at Eurofins Genomics) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
Ebersberg |
Persigehl, Peter (Eurofins 201405 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Poddevin, Bruno (Eurofins 201007 SVP Genomic Services) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
Ebersberg |
Schlossmacher, Julian (Eurofins 202004 Head of Marketing + Communications Europe at Eurofins Genomics) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Ebersberg |
Weichselgartner, Michael |
n. a. |
Eurofins (Group) |
Ebersberg |
Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Ebersberg |
Winzer, Ludwig (Ocimum Germany GmbH 200606– Managing Director) |
Managing Director |
Ficus Enterprises (Group) |
Ebersberg |
Lehrke, Ingo (Algiax Pharmaceuticals 2019– CEO + Tubulis 202007 CBO) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Erkrath |
Beils, Fernando (Siemens 201712 Head of Molecular Diagnostics at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Erlangen |
Bundis, Florian (Peqlab 200809) |
n. a. |
Avantor (Group) |
Erlangen |
Dillione, Janet (Siemens 200703 President Health Service) |
n. a. |
Siemens (Group) |
Erlangen |
Foulsham, Lawrence (Siemens 202310 Business Manager for Molecular Imaging at Siemens Healthineers GB&I) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Erlangen |
Gröppel, Manfred (Mallia Therapeutics 202307 CEO + Co-Founer before Immunic + 4SC) |
Chief Executive Officer (CEO) |
Mallia Therapeutics GmbH |
Erlangen |
Hardung, Kerstin (Peqlab 200809) |
n. a. |
Avantor (Group) |
Erlangen |
Kaindl, Arthur (Siemens Healthineers 202301 Head of Magnetic Resonance) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Erlangen |
Kocher, Jean-Pierre (Molecular Networks 200308– Managing Director) |
Managing Director |
Molecular Networks GmbH – Computerchemie |
Erlangen |
Koebernick, Marc (Siemens 202008 Head of Investor Relations at Siemens Healthineers AG) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Erlangen |
Kraemer, Matthias (Siemens 202101 at Siemens Healthineers) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Erlangen |
Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Erlangen |
Longwell, Lance (Siemens 202104 Director of Communications + PR at Siemens Healthineers) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Erlangen |
Mischau, Reinhold (Peqlab Biotechnologie GmbH 200710 Managing Director) |
Managing Director |
Avantor (Group) |
Erlangen |
Montag, Bernd (Siemens 201802 CEO of Siemens Healthineers) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Erlangen |
Naraghi, Mohammad (Siemens Medical Solutions 200603 Head of Business Development) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Erlangen |
Pacitti, David (Siemens 202104 President + Head of the Americas at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Erlangen |
Reindl, Max (Wavelight CEO + Founder) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Erlangen |
Reinhardt, Erich R. (Siemens Medical Solutions 200604 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Erlangen |
Sampath, Rangarajan (Siemens 202112 Head of Center for Innovation in Diagnostics at Siemens Healthineers) |
President/Director/Head of Research Organisation/Unit |
Siemens (Group) |
Erlangen |
Staudinger, Elisabeth (Siemens 202010 President Asia Pacific at Siemens Healthineers) |
President/Director/Head Business Group/Unit/Division |
Siemens (Group) |
Erlangen |
Stein, David (Siemens 201605 Head Strategy + Innovation at Siemens Healthineers) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Erlangen |
Steinkasserer, Alexander (Univ Erlangen-Nürnberg 202307 Head Dept Immune Modulation + Mallia Therapeutics) |
Professor |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Erlangen |
Weiner, Olaf (directif GmbH 200503 Managing Director) |
Chief Executive Officer (CEO) |
November (Group) |
Erlangen |
Williams, James (Siemens 201304 CEO of Siemens Molecular Imaging business unit) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Erlangen |
Reitermann, Michael (Siemens 201306 CEO of Siemens Healthcare Diagnsotics before President Molecular Imaging) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Eschborn |
Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) |
Professor |
University of Duisburg-Essen |
Essen |
Homberg, Peter (Dentons/Salans 201211 Partner Ffm before Raupach & Wollter-Elmendorff + Jones Day + Roche) |
Attorney / Lawyer |
Dentons (Group) |
Frankfurt am Main |
Falch, Siegfried (JEOL 201002 Managing Director JEOL (Germany) GmbH) |
Managing Director |
JEOL (Group) |
Freising |
Gleba, Yurijus (Yuri) (Icon Genetics 200501 CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Freising |
Hahne, Hannes (OmicScouts GmbH 201407– Managing Director + Co-Founder) |
Managing Director |
OmicScouts GmbH |
Freising |
Hohlbaum, Andreas (Pieris 201110 VP Strategic Research + Project Management before Director Science + Precl Developm) |
Research & Development Manager |
Pieris (Group) |
Freising |
Küster, Bernhard (Technical Univ Munich 201107 Professor Proteomics + Bioanalytics) |
Professor |
Technical University Munich (TU München, TUM) |
Freising |